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Image in Focus
a St. John Hospital and Medical Center, Department of Pathology. Detroit, Michigan, USA.
Figure 1. Macroscopic appearance of the brain depicting complex gyration without classical sulcal landmarks 
(A and B) and focal polymicrogyria (A), flattened cerebral hemispheres surrounding a single cystically dilated 
ventricle (C), fused right and left basal ganglia and diencephalic structures (C), unremarkable midbrain, cerebellum 
and medulla (D).
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Holoprosencephaly (HPE) is a brain malformation 
resulting from failure of prosencephalon (the forebrain 
of the embryo) to divide into two distinct cerebral 
hemispheres .  I t  i s  the  most  common bra in 
malformation with an incidence of 1:250 during 
embryogenesis and 1:16,000 among live births.1 
HPE has four subtypes: alobar holoprosencephaly, 
semilobar holoprosencephaly, lobar holoprosencephaly, 
and a middle interhemispheric fusion variant 
(syntelencephaly).2 Alobar holoprosencephaly is 
the most severe form, and as the name implies, 
there is no separation of the cerebral hemispheres. 
In semilobar holoprosencephaly, the cerebral 
hemispheres separate posteriorly, however are fused 
anteriorly. Lobar holoprosencephaly is characterized 
by almost complete separation of the cerebral 
hemispheres. Syntelencephaly results from failure 
of separation of posterior frontal and parietal lobes. 
Since both the forebrain and midface arise from 
the prechordal mesoderm, majority of patients 
with HPE also manifest craniofacial abnormalities 
such as microcephaly, microphthalmia, cleft lip and 
palate, flat nose, absent nasal bridge, and cyclopia. 
Multiple genetic and environmental factors are 
involved in the pathogenesis of HPE. Maternal diabetes 
mellitus is a well-known risk factor.3 Exposure to 
retinoic acid, diphenylhydantoin, aspirin, misoprostol, 
methotrexate, cholesterol-lowering agents and alcohol 
during pregnancy have been associated with HPE.4-9 
Other environmental factors include TORCH infections 
during early pregnancy.1 Genetic abnormalities 
associated with HPE include trisomy 13, trisomy 
18, and triploidy.10,11 Syndromic association of HPE 
includes, but is not limited to Smith-Lemli-Opitz 
syndrome, Genoa syndrome, Meckel-Gruber syndrome, 
Lambotte syndrome, Pallister-Hall syndrome, Steinfeld 
syndrome, caudal dysgenesis and Aicardi syndrome.12-19 
Mutations in SHH, ZIC2, SIX3, and TGIF genes have 
been implicated in non-syndrome associated HPE.20
Central nervous system abnormalities are identified 
on routine prenatal imaging and etiologic diagnosis can 
be done by prenatal or postnatal karyotype and testing 
for known gene mutations. Sub classification is based 
on MRI findings or autopsy findings if one is requested.
Infants who survive have a myriad of clinical 
presentation. Some of the common physical findings 
include spasticity, hypotonia, choreoathetosis and 
dystonia. Infantile spasms and seizures are common. 
Feeding difficulties, gastroesophageal reflux, and 
malnutrition occur commonly. Other problems include 
temperature dysregulation and respiratory tract 
infections. Death usually occurs due to brainstem 
dysfunction or manifestation and complications of 
associated syndromes. Treatment is mainly supportive.
Prognosis depends upon subtype and associated 
syndrome.21 Those with alobar type die within days of 
birth.22 Around 50% with the isolated semilobar form 
survive beyond 1 year.22 Recurrence risk in subsequent 
pregnancies is high in established cases of parental 
carrier state and is low if the genetic abnormalities 
occur de novo.23,24
Figure 1 refers to gross appearance of brain 
in a 7-hour old female infant born to a 41-year old 
G1 P0 lady with limited prenatal care, past medical 
history of diabetes mellitus type 2 and alcohol use 
during first trimester of the pregnancy. On prenatal 
ultrasonography, the fetus had hydrocephalous and 
suboptimal development of cerebral and cerebellar 
hemispheres. Karyotyping showed normal signal 
pattern for chromosomes 13, 18 and 21.
Autopsy findings included fetal macrosomia; 
craniofacial dysmorphogenesis to include hypertelorism, 
low set ears, cleft palate, absent nasal bridge and 
bossing of forehead; biventricular cardiomegaly, 
muscular ventricular septal defect and imperforated 
anus.
The detailed brain examination revealed flattened 
frontal, temporal and occipital lobes with a rudimentary 
C-shaped interhemispheric fissure. The surface of 
the cystically dilated forebrain displayed complex 
gyration; however, without classical sulcal landmarks 
(Figure 1A and 1B). There were focal polymicrogyria 
patches (Figure 1A). Cortical pallium surrounded 
a single large cystic cavity (telencephalic vesicle) in 
which lateral ventricles and ventricular horns could 
not be discerned (Figure 1 C). At the base of cystically 
dilated cerebrum, there were fused right and left basal 
ganglia and diencephalic structures (Figure 1C). There 
was no corpus callosum. The midbrain, cerebellum and 
medulla appeared unremarkable (Figure 1D).
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